Authors
Loading...
Experimental study reveals that central melanocortin pathway activation mediates fenfluramine-induced appetite suppression in rodents, highlighting a selective target for obesity treatments.
Heisler et al. (2002) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: